CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia von Chong, Elise A., Levine, Bruce L, Grupp, Stephan A., Davis, Megan, Siegel, Don L., Maude, Shannon L., Gladney, Whitney Lynn, Frey, Noelle V., Porter, David L., June, Carl H, Schuster, Stephen J.

Volltext

Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma von Garfall, Alfred L., Cohen, Adam D., Lacey, Simon F, Tian, Lifeng, Hwang, Wei-Ting, Vogl, Dan T., Waxman, Adam, Lancaster, Eric, Nelson, Anne Marie, Ferthio, Regina, Fesnak, Andrew, Lamontagne, Anne, Brennan, Andrea, Guilliams, Jamie, Gladney, Whitney Lynn, Melenhorst, J. Joseph, Young, Regina M, Siegel, Don L., Levine, Bruce L, Brogdon, Jennifer, Isaacs, Randi E., June, Carl H, Milone, Michael C., Stadtmauer, Edward A.

Volltext

Prospective Clinical Trial of Anti-CD19 CAR T Cells in Combination with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia Shows a High Response Rate von Gill, Saar I., Vides, Vanessa, Frey, Noelle V., Metzger, Susan, O'Brien, Megan, Hexner, Elizabeth, Mato, Anthony R., Lacey, Simon F, Melenhorst, J. Joseph, Pequignot, Edward, Gladney, Whitney Lynn, Hwang, Wei-Ting, Lamontagne, Anne, Davis, Megan, Byrd, John C., Schuster, Stephen J., Siegel, Don L., Isaacs, Randi E., June, Carl H, Porter, David L.

Volltext